Molecular and clinical characterization of <i>ETNK1</i>-mutated myeloid neoplasms: the Mayo Clinic experience-Reference-Cited by-同舟云学术

Molecular and clinical characterization of ETNK1-mutated myeloid neoplasms: the Mayo Clinic experience

Published:2024-09-24 Issue:18 Volume:8 Page:4807-4811
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Tessier Steven¹^ORCID,He Rong²^ORCID,Greipp Patricia²^ORCID,Viswanatha David²,Bessonen Kurt²,Lasho Terra³,Foran James⁴,Arana-Yi Cecilia⁵^ORCID,Gangat Naseema³^ORCID,Tefferi Ayalew³,Shah Mithun³^ORCID,Alkhateeb Hassan³,Liu Shujun⁶,Pardanani Animesh³,Patnaik Mrinal³^ORCID,Al-Kali Aref³^ORCID

Affiliation:

1. 1Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education, Rochester, MN

2. 2Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

3. 3Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

4. 4Division of Hematology, Department of Medicine, Mayo Clinic, Jacksonville, FL

5. 5Division of Hematology, Department of Medicine, Mayo Clinic, Phoenix, AZ

6. 6Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH

Publisher

American Society of Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/8/18/4807/2241509/blooda_adv-2024-013255-main.pdf

Reference15 articles.

1. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia;Gambacorti-Passerini;Blood,2015

2. Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia;Lasho;Blood Cancer J,2015

3. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms;Khoury;Leukemia,2022

4. International Consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data;Arber;Blood,2022

5. ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia;Shuai;Cancer,2023